Society of Biological Psychiatry 73rd Annual Scientific Convention

The 73rd Annual Scientific Convention of the Society of Biological Psychiatry meets in New York City May 10 to 12. Attendees will hear the latest research about neuroscience and psychiatry, with a special focus this year on biomarkers and biomodels. Sign up for our daily email blasts on our registration page, and check back here during the conference for full coverage.
 
May 12, 2018
In a poster presentation at the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York, New York, May 10 to 12, researchers reported about an adjunctive investigational drug therapy for major depressive disorder, alone and together with a selective serotonin reuptake inhibitor (SSRI), in rats resistant to SSRIs.
May 11, 2018
The field of posttraumatic stress disorder (PTSD) has grown in recent years due to veterans returning from wars in Afghanistan and Iraq, and at the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York City, May 10 to 12, one of the nation’s leading experts decided to focus his presentation on the topic on memory consolidation.
May 11, 2018
Our knowledge of the human microbiome has only been developed over the past decade, according to Elaine Hsaio, PhD, assistant professor of integrative biology and physiology at the University of California, Los Angeles, at the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York City, May 10 to 12. Hsaio presented about how the microbiome influences brain function, development and behavior.
 
May 11, 2018
Chronic pain is a serious problem in the United States and particularly so for veterans. At the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York City, May 10 to 12, Jennifer C. Naylor, PhD, presented results from a randomized control trial of 92 veterans with chronic low back pain treated with pregnenolone or placebo.
May 10, 2018
In a poster presentation at the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York, New York, May 10 to 12, researchers reported on the ability of the addition of an opioid receptor antagonist to address the abuse potential of an adjunctive investigational drug therapy for major depressive disorder.
May 10, 2018
It is now known that early life stress may have an impact on adults later in life, and that men and women may respond to depression differently, but why that is so is not thoroughly understood. At the 73rd Annual Scientific Convention of the Society of Biological Psychiatry meeting in New York City, May 10 to 12, Eric J. Nestler, MD, PhD, gave an opening plenary called “Sex Differences in the Molecular Basis of Depression.”
This page contains sponsored advertising
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.